|
1.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2.
|
Perou CM, Sørlie T, Eisen MB, van De Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Anderson WF and Matsuno R: Breast cancer
heterogeneity: a mixture of at least two main types? J Natl Cancer
Inst. 98:948–951. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Børresen-Dale AL, Sørlie T and Kristensen
VN: On the molecular biology of breast cancer. Mol Oncol.
4:171–173. 2010.
|
|
5.
|
Sørlie T, Perou CM, Tibshirani R, Aas T,
Geisler S, Johnsen H, Hastie T, Eisen MB, van De Rijn M, Jeffrey
SS, et al: Gene expression patterns of breast carcinomas
distinguish tumor subclasses with clinical implications. Proc Natl
Acad Sci USA. 98:10869–10874. 2001.PubMed/NCBI
|
|
6.
|
Baum M, Demicheli R, Hrushesky W and
Retsky MW: Does surgery unfavourably perturb the ‘natural history’
of early breast cancer by accelerating the appearance of distant
metastases? Eur J Cancer. 41:508–515. 2005.PubMed/NCBI
|
|
7.
|
Demicheli R, Retsky MW, Hrushesky WJM,
Baum M and Gukas ID: The effects of surgery on tumor growth: a
century of investigations. Ann Oncol. 19:1821–1828. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Fehm T, Mueller V, Marches R, Klein G,
Gueckel B, Neubauer H, Solomayer E and Becker S: Tumor cell
dormancy: implications for the biology and treatment of breast
cancer. Acta Pathol Microbiol Immunol Scand. 116:742–753. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Tseng WW, Fadaki N and Leong SP:
Metastatic tumor dormancy in cutaneous melanoma: Does surgery
induce escape? Cancers. 3:730–746. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Retsky MW, Demicheli R, Hrushesky W, Baum
M and Gukas I: Surgery triggers outgrowth of latent distant disease
in breast cancer: An inconvenient truth? Cancers. 2:305–337. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Uhr JW and Pantel K: Controversies in
clinical cancer dormancy. Proc Natl Acad Sci USA. 108:1–5.
2011.
|
|
12.
|
Demicheli R, Retsky MW, Hrushesky WJM and
Baum M: Tumor dormancy and surgery-driven interruption of dormancy
in breast cancer: learning from failures. Nat Clin Pract Oncol.
4:699–710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Aguirre-Ghiso JA: Models, mechanisms and
clinical evidence for cancer dormancy. Nat Rev Cancer. 7:834–846.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Coffey JC, Wang JH, Smith MJF,
Bouchier-Hayes D, Cotter TG and Redmond HP: Excisional surgery for
cancer cure: therapy at a cost. Lancet Oncol. 4:760–768. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Spurrier B, Honkanen P, Holway A, Kumamoto
K, Terashima M, Takenoshita S, Wakabayashi G, Austin J and
Nishizuka S: Protein and lysate array technologies in cancer
research. Biotechnol Adv. 26:361–369. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Mueller C, La Liotta and Espina V: Reverse
phase protein microarrays advance to use in clinical trials. Mol
Oncol. 4:1–21. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Sheehan KM, Calvert VS, Kay EW, Lu Y,
Fishman D, Espina V, Aquino J, Speer R, Araujo R, Mills GB, et al:
Use of reverse phase protein microarrays and reference standard
development for molecular network analysis of metastatic ovarian
carcinoma. Mol Cell Proteomics. 4:346–355. 2005. View Article : Google Scholar
|
|
18.
|
Tibes R, Qiu Y, Lu Y, Hennessy B, Andreeff
M, Mills GB and Kornblau SM: Reverse phase protein array:
validation of a novel proteomic technology and utility for analysis
of primary leukemia specimens and hematopoietic stem cells. Mol
Cancer Ther. 5:2512–2521. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Brennan DJ, O’Connor DP, Rexhepaj E,
Ponten F and Gallagher WM: Antibody-based proteomics: fast-tracking
molecular diagnostics in oncology. Nat Rev Cancer. 10:605–617.
2010. View
Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Grote T, Siwak DR, Fritsche HA, Joy C,
Mills GB, Simeone D, Whitcomb DC and Logsdon CD: Validation of
reverse phase protein array for practical screening of potential
biomarkers in serum and plasma: accurate detection of CA19-9 levels
in pancreatic cancer. Proteomics. 8:3051–3060. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Holdaway IM, Lethaby AE, Mason BH, Singh
V, Harman JE, MacCormick M and Civil ID: Effect of breast surgery
on serum levels of insulin-like growth factors (IGF-I, IGF-II, and
IGF binding protein-3) in women with benign and malignant breast
lesions. Ann Surg Oncol. 8:25–31. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Smyth GK: Limma: linear models for
microarray data. Bioinformatics and Computational Biology Solutions
using R and Bioconductor. Gentleman R, Carey V, Dudoit S, Irizarry
R and Huber W: Springer; New York, NY: pp. 397–420. 2005,
View Article : Google Scholar
|
|
23.
|
Yang YH and Thorne NP: Normalization for
two-color cDNA microarray data. Institute of Mathematical
Statistics; 2003
|
|
24.
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Gen Mol Biol. 3:Article3, Feb 12, 2004 (Epub
ahead of print).
|
|
25.
|
Benjamini Y and Hochberg Y: Controlling
the false discovery rate: A practical and powerful approach to
multiple testing. J Roy Stat Soc Ser B (Stat Method). 57:289–300.
1995.
|
|
26.
|
Carlsson A, Wingren C, Kristensson M, Rose
C, Fernö M, Olsson H, Jernström H, Ek S, Gustavsson E, Ingvar C, et
al: Molecular serum portraits in patients with primary breast
cancer predict the development of distant metastases. Proc Natl
Acad Sci USA. 108:14252–14257. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Gurtner GC, Werner S, Barrandon Y and
Longaker MT: Wound repair and regeneration. Nature. 453:314–321.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Hamilton JA: Colony-stimulating factors in
inflammation and autoimmunity. Nat Rev Immunol. 8:533–544. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Lin Z-Q, Kondo T, Ishida Y, Takayasu T and
Mukaida N: Essential involvement of IL-6 in the skin wound-healing
process as evidenced by delayed wound healing in IL-6-deficient
mice. J Leukoc Biol. 73:713–721. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Oshika Y, Masuda K, Tokunaga T, Hatanaka
H, Kamiya T, Abe Y, Ozeki Y, Kijima H, Yamazaki H, Tamaoki N, et
al: Thrombospondin 2 gene expression is correlated with decreased
vascularity in non-small cell lung cancer. Clin Cancer Res.
4:1785–1788. 1998.PubMed/NCBI
|
|
31.
|
Tokunaga T, Nakamura M, Oshika Y, Abe Y,
Ozeki Y, Fukushima Y, Hatanaka H, Sadahiro S, Kijima H, Tsuchida T,
et al: Thrombospondin 2 expression is correlated with inhibition of
angiogenesis and metastasis of colon cancer. Br J Cancer.
79:354–359. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Maclauchlan S, Skokos EA, Agah A, Zeng J,
Tian W, Davidson JM, Bornstein P and Kyriakides TR: Enhanced
angiogenesis and reduced contraction in thrombospondin-2-null
wounds is associated with increased levels of matrix
metalloproteinases-2 and -9, and soluble VEGF. J Histochem
Cytochem. 57:301–313. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Kyriakides TR, Tam JW and Bornstein P:
Accelerated wound healing in mice with a disruption of the
thrombospondin 2 gene. J Invest Dermatol. 113:782–787. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Jameson J and Havran WL: Skin gammadelta
T-cell functions in homeostasis and wound healing. Immunol Rev.
215:114–122. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Al-Rawi MAA, Watkins G, Mansel RE and
Jiang WG: The effects of interleukin-7 on the lymphangiogenic
properties of human endothelial cells. Int J Oncol. 27:721–730.
2005.PubMed/NCBI
|
|
36.
|
Cruikshank W and Little F: lnterleukin-16:
the ins and outs of regulating T-cell activation. Crit Rev Immunol.
28:467–483. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Stabile E, Kinnaird T, la Sala A, Hanson
SK, Watkins C, Campia U, Shou M, Zbinden S, Fuchs S, Kornfeld H, et
al: CD8+ T lymphocytes regulate the arteriogenic
response to ischemia by infiltrating the site of collateral vessel
development and recruiting CD4+ mononuclear cells
through the expression of interleukin-16. Circulation. 113:118–124.
2006.
|
|
38.
|
Al-Rawi MAA, Rmali K, Watkins G, Mansel RE
and Jiang WG: Aberrant expression of interleukin-7 (IL-7) and its
signalling complex in human breast cancer. Eur J Cancer.
40:494–502. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Germano G, Allavena P and Mantovani A:
Cytokines as a key component of cancer-related inflammation.
Cytokine. 43:374–379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Studebaker AW, Storci G, Werbeck JL,
Sansone P, Sasser AK, Tavolari S, Huang T, Chan MWY, Marini FC,
Rosol TJ, et al: Fibroblasts isolated from common sites of breast
cancer metastasis enhance cancer cell growth rates and invasiveness
in an interleukin-6-dependent manner. Cancer Res. 68:9087–9095.
2008. View Article : Google Scholar
|
|
41.
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
|
|
42.
|
Carlsson A, Wingren C, Ingvarsson J,
Ellmark P, Borrebaeck CAK, Baldertorp B, Fernö M and Olsson H:
Serum proteome profiling of metastatic breast cancer using
recombinant antibody microarrays. Eur J Cancer. 44:472–480. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Gast M-CW, Zapatka M, van Tinteren H,
Bontenbal M, Span PN, Tjan-Heijnen VCG, Knol JC, Jimenez CR,
Schellens JHM and Beijnen JH: Postoperative serum proteomic
profiles may predict recurrence-free survival in high-risk primary
breast cancer. J Cancer Res Clin Oncol. 137:1773–1783. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Pietrowska M, Polanska J, Marczak L,
Behrendt K, Nowicka E, Stobiecki M, Polanski A, Tarnawski R and
Widlak P: Mass spectrometry-based analysis of therapy-related
changes in serum proteome patterns of patients with early-stage
breast cancer. J Transl Med. 8:662010. View Article : Google Scholar : PubMed/NCBI
|
